Updates are available Correction dated 2023-01-03

Article History

Received: 21 September 2022

Accepted: 3 October 2022

First Online: 4 November 2022

Change Date: 31 December 2022

Change Type: Update

Change Details: In the published article, the author would like to update the following lines History of Gastrointestinal symptoms were observed in 31% (n=319) participants and, of these, 85% (n =271) were upper gastrointestinal

Change Date: 3 January 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40520-022-02319-1

Declarations

:

: NRF, NA-D, OBo, JB, ECav, MdW, PH, NCH, JMK, AK, RM, SMi, SP, JAK, RR, CC have no conflicts of interest to declare. OBr reports consulting or lecture fees for Amgen, Aptissen, Biophytis, IBSA, MEDA, Mylan, Novartis, Sanofi, TRB Chemedica, UCB, Viatris outside this manuscript. ECas reports Advisory Board participation and lecture fees for Theramex. BC reports Advisory Board participation and lecture fees for Theramex and Advisory Board participation for Expanscience. AG reports consulting and lecture fees from Abiogen Pharma, Theramex, and Bruno. MH has received research grants through institution from Radius Health, Amgen and ViiV Healthcare, lecture fees from Teva and Mylan Pharmaceuticals and consulting fees from UCB. SMa has received grants from Sanofi, MSD, GSK, Pfizer and Viatris outside of the submitted work. RPR has received fees for lectures or scientific advisory boards from Abiogen, Danone, Echolight, European Milk Forum, ObsEva, Pfizer Consumer Health and Theramex. FT reports Advisory Board participation and lecture fees for Theramex. NV reports personal fees from IBSA, Mylan, Viatris, Fidia, MSD outside of the submitted work. JYR reports consulting fees or paid advisory boards for IBSA-Genevrier, Mylan, Radius Health, Pierre Fabre, Faes Pharma, Rejuvenate Biomed, Samumed, Teva, Theramex, Pfizer, Mithra Pharmaceutical; lecture fees when speaking at the invitation of sponsor for IBSA-Genevrier, Mylan, CNIEL, Dairy Research Council (DRC), Nutricia, Danone, Agnovos and grant support (through institution) from IBSA-Genevrier, Mylan, CNIEL, Radius Health, TRB.

: For this retrospective review, formal consent is not required.

: The choice of topics, participants, content and agenda of the Working Groups as well as the writing, editing, submission and reviewing of the manuscript are the sole responsibility of the ESCEO, without any influence from third parties.

: This article is a retrospective review. To the authors’ knowledge, the reviewed studies were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.